Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.9811.9513.0515.315.81

What is the latest EV/Core EBITDA ratio of AARTI DRUGS ?

The latest EV/Core EBITDA ratio of AARTI DRUGS is 13.98 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202413.98
Mar202311.95
Mar202213.05
Mar202115.31
Mar20205.81

How is EV/Core EBITDA of AARTI DRUGS Trending?

Years EV/Core EBITDA % Change
Mar2024 13.98
16.99
Mar2023 11.95
-8.43
Mar2022 13.05
-14.76
Mar2021 15.31
163.51
Mar2020 5.81 -

Other Financial Ratios of AARTI DRUGS


Compare EV/Core EBITDA ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,129.5 Cr 4.7% -0.5% -7.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,838.0 Cr 1% 4.6% 47.5% Stock Analytics
DIVIS LABORATORIES ₹156,107.0 Cr 1% -3.2% 59.3% Stock Analytics
CIPLA ₹120,270.0 Cr -1.1% -0.3% 20.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,077.0 Cr 2.2% 12.1% 21.6% Stock Analytics
ZYDUS LIFESCIENCES ₹96,553.2 Cr -2.7% 0.8% 43.8% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

4.7%

-0.5%

-7.7%

SENSEX

-2.1%

-2%

11.3%


You may also like the below Video Courses